Extracellular vesicle-associated organotropic metastasis.

cancer exosomes extracellular vesicles metastasis microvesicles organotropism

Journal

Cell proliferation
ISSN: 1365-2184
Titre abrégé: Cell Prolif
Pays: England
ID NLM: 9105195

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 18 08 2020
revised: 28 09 2020
accepted: 14 10 2020
pubmed: 5 11 2020
medline: 20 1 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Metastasis refers to the progressive dissemination of primary tumour cells and their colonization of other tissues and is associated with most cancer-related mortalities. The disproportional and systematic distribution pattern of distant metastasis in different cancers has been well documented, as is termed metastatic organotropism, a process orchestrated by a combination of anatomical, pathophysiological, genetic and biochemical factors. Extracellular vesicles (EVs), nanosized cell-derived membrane-bound particles known to mediate intercellular communication, are now considered crucial in organ-specific metastasis. Here, we review and summarize recent findings regarding EV-associated organotropic metastasis as well as some of the general mechanisms by which EVs contribute to this important process in cancer and provide a future perspective on this emerging topic. We highlight studies that demonstrate a role of tumour-derived EVs in organotropic metastasis via pre-metastatic niche modulation. The bioactive cargo carried by EVs is of diagnostic and prognostic values, and counteracting the functions of such EVs may be a novel therapeutic strategy targeting metastasis. Further investigations are warranted to better understand the functions and mechanisms of EVs in organotropic metastasis and accelerate the relevant clinical translation.

Identifiants

pubmed: 33145869
doi: 10.1111/cpr.12948
pmc: PMC7791170
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12948

Subventions

Organisme : National University of Singapore
ID : R-184-000-295-733
Organisme : City University of Hong Kong Jockey Club College of Veterinary Medicine and Life Sciences

Informations de copyright

© 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Références

Trends Mol Med. 2011 Jul;17(7):347-62
pubmed: 21481637
Sci Rep. 2017 May 16;7(1):1991
pubmed: 28512335
Nano Lett. 2019 May 8;19(5):2993-3001
pubmed: 30964695
Elife. 2019 May 30;8:
pubmed: 31144616
Nat Commun. 2019 Mar 27;10(1):1387
pubmed: 30918259
J Lipid Res. 2018 Oct;59(10):1793-1804
pubmed: 29678957
J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80
pubmed: 16025223
Front Mol Neurosci. 2017 Aug 31;10:276
pubmed: 28912682
Nat Commun. 2019 Dec 2;10(1):5476
pubmed: 31792209
J Cell Sci. 2019 Jul 1;132(13):
pubmed: 31263077
ACS Appl Mater Interfaces. 2020 Jan 29;12(4):5136-5146
pubmed: 31894690
J Natl Cancer Inst. 2015 May 13;107(7):
pubmed: 25972604
Trends Cancer. 2015 Sep;1(1):76-91
pubmed: 28741564
Cancer Metastasis Rev. 2016 Dec;35(4):669-676
pubmed: 27838868
Exp Mol Med. 2019 Mar 15;51(3):1-12
pubmed: 30872574
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Lancet Oncol. 2006 Nov;7(11):925-34
pubmed: 17081918
J Extracell Vesicles. 2019 Apr 14;8(1):1599680
pubmed: 31044053
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
ACS Nano. 2019 Dec 24;13(12):13853-13865
pubmed: 31479239
Sci Adv. 2020 Mar 11;6(11):eaaz6162
pubmed: 32195353
Carcinogenesis. 2018 Dec 13;39(11):1368-1379
pubmed: 30184100
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
Mol Ther. 2017 Jan 4;25(1):181-191
pubmed: 28129113
Adv Exp Med Biol. 2019;1152:105-129
pubmed: 31456182
Nat Rev Cancer. 2016 Apr;16(4):201-18
pubmed: 27009393
Cells. 2018 Aug 01;7(8):
pubmed: 30071693
Diabetologia. 2019 Dec;62(12):2179-2187
pubmed: 31690986
Stem Cells. 2017 Apr;35(4):851-858
pubmed: 28294454
Int J Biol Sci. 2020 Jan 1;16(4):620-632
pubmed: 32025210
Gene. 2018 Aug 5;666:116-122
pubmed: 29730429
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
Dev Cell. 2019 May 6;49(3):375-391
pubmed: 31063756
Cancer Res. 2018 Aug 1;78(15):4316-4330
pubmed: 30026327
Liver Int. 2006 Dec;26(10):1175-86
pubmed: 17105582
J Extracell Vesicles. 2013 Jun 18;2:
pubmed: 24009892
J Clin Invest. 2016 Apr 1;126(4):1224-32
pubmed: 27035813
Surg Clin North Am. 2010 Aug;90(4):643-53
pubmed: 20637938
Int J Cancer. 2005 Feb 20;113(5):752-60
pubmed: 15499615
Nat Rev Cancer. 2005 Jan;5(1):21-8
pubmed: 15630412
Am J Respir Crit Care Med. 2015 Oct 1;192(7):799-809
pubmed: 26131844
Cancer Res. 2010 Dec 1;70(23):9621-30
pubmed: 21098712
Cell Adh Migr. 2015;9(5):345-56
pubmed: 26312653
J Extracell Vesicles. 2017 Sep 3;6(1):1369805
pubmed: 28959386
Cell Mol Life Sci. 2017 Feb;74(4):697-713
pubmed: 27582126
J Cell Biochem. 2018 Jun;119(6):4711-4716
pubmed: 29278659
Circ Res. 2018 Jan 19;122(2):197-198
pubmed: 29348245
Nat Commun. 2018 Dec 19;9(1):5395
pubmed: 30568162
PLoS One. 2014 Apr 16;9(4):e95240
pubmed: 24740415
Nature. 2018 Aug;560(7718):382-386
pubmed: 30089911
Connect Tissue Res. 2018 Mar;59(2):99-107
pubmed: 28324674
Cancer Metastasis Rev. 1989 Aug;8(2):98-101
pubmed: 2673568
J Extracell Vesicles. 2018 Mar 13;7(1):1446660
pubmed: 29696074
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Nat Rev Urol. 2020 Jan;17(1):11-27
pubmed: 31827264
Cancer Cell. 2014 Apr 14;25(4):501-15
pubmed: 24735924
Am J Physiol Cell Physiol. 2016 Jul 1;311(1):C1-C14
pubmed: 27076614
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Mol Cell Proteomics. 2014 Dec;13(12):3558-71
pubmed: 25271300
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
Oncogene. 2019 Mar;38(10):1751-1763
pubmed: 30353168
Clin Chim Acta. 2016 Feb 15;454:28-32
pubmed: 26724367
Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412
pubmed: 25561720
Neuro Oncol. 2020 Jul 7;22(7):967-978
pubmed: 32080744
Nat Commun. 2020 Mar 5;11(1):1211
pubmed: 32139701
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
J Clin Invest. 2016 Apr 1;126(4):1139-43
pubmed: 27035805
Nat Commun. 2017 Apr 10;8:15016
pubmed: 28393839
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2204-2209
pubmed: 29440427
Clin Cancer Res. 2007 Dec 1;13(23):7003-11
pubmed: 18056176
Mol Cancer. 2019 Dec 3;18(1):175
pubmed: 31796058
Mol Cell Proteomics. 2012 Aug;11(8):230-43
pubmed: 22345510
Nat Commun. 2014 Apr 07;5:3591
pubmed: 24710016
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Nat Cell Biol. 2019 Feb;21(2):190-202
pubmed: 30598531
Br J Cancer. 2019 Jul;121(1):5-14
pubmed: 31110329
Nat Commun. 2017 Feb 16;8:14450
pubmed: 28205552
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7022-7027
pubmed: 29915060
Cancer Res. 2016 Dec 1;76(23):6816-6827
pubmed: 27760789
Br J Cancer. 2020 Mar;122(6):801-811
pubmed: 31937922
Cancer Cell. 2019 Jan 14;35(1):33-45.e6
pubmed: 30645975
Vaccine. 2008 Jul 4;26(29-30):3662-72
pubmed: 18538453
Front Immunol. 2018 Jul 03;9:1534
pubmed: 30018618
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24012-24018
pubmed: 31732668
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Oncotarget. 2016 Dec 27;7(52):86999-87015
pubmed: 27894104
J Cell Sci. 2010 May 15;123(Pt 10):1603-11
pubmed: 20445011
Mol Ther. 2017 Jul 5;25(7):1665-1675
pubmed: 28284981
Commun Biol. 2019 Oct 18;2:386
pubmed: 31646189
Nat Biomed Eng. 2017;1:
pubmed: 28791195
Nat Cell Biol. 2019 Nov;21(11):1403-1412
pubmed: 31685984
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
J Virol. 2018 Oct 12;92(21):
pubmed: 30111566
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Clin Cancer Res. 2018 Jan 1;24(1):181-188
pubmed: 29051321
Elife. 2016 Feb 27;5:e10250
pubmed: 26920219
Nat Commun. 2015 Apr 01;6:6716
pubmed: 25828099
Mol Cancer. 2018 Mar 20;17(1):74
pubmed: 29558959
Cancer Sci. 2016 Apr;107(4):385-90
pubmed: 26797692
Comp Hepatol. 2002 Aug 23;1(1):1
pubmed: 12437787
Theranostics. 2019 Oct 17;9(26):8001-8017
pubmed: 31754377
Trends Mol Med. 2019 May;25(5):382-394
pubmed: 30853173
Nat Rev Immunol. 2019 Nov;19(11):660-661
pubmed: 31591534
Exp Mol Med. 2020 Jan;52(1):1-6
pubmed: 31915368
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7786-E7794
pubmed: 30061414
Sci Transl Med. 2019 May 15;11(492):
pubmed: 31092696
Cancer Metastasis Rev. 2008 Mar;27(1):41-55
pubmed: 18071636
Circ Res. 2017 May 12;120(10):1649-1657
pubmed: 28495995
Clin Cancer Res. 2017 Jul 15;23(14):3721-3733
pubmed: 28053020
Br J Cancer. 2012 Feb 14;106(4):768-74
pubmed: 22240788
N Engl J Med. 2018 Sep 06;379(10):958-966
pubmed: 30184457
Mol Cancer Res. 2016 Nov;14(11):1136-1146
pubmed: 27439335
Cell Prolif. 2021 Jan;54(1):e12948
pubmed: 33145869
Sci Rep. 2018 May 29;8(1):8267
pubmed: 29844613
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Zhenzhen Mo (Z)

Department of Paediatrics, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Jia Yang Alex Cheong (JYA)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Lirong Xiang (L)

Department of Paediatrics, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Minh T N Le (MTN)

Institute for Digital Medicine and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Andrew Grimson (A)

Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.

Daniel Xin Zhang (DX)

Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.
Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH